(Q45017876)

8 December 2017

title

Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China (English)

1 reference

8 December 2017

main subject

Cryptococcus neoformans

1 reference

Li-Ping Zhu

1

1 reference

8 December 2017

Cristina Gil-Lamaignere

series ordinal

2

1 reference

8 December 2017

Frank-Michael C Müller

series ordinal

3

1 reference

8 December 2017

publication date

1 August 2004

1 reference

8 December 2017

1 reference

8 December 2017

volume

47

1 reference

8 December 2017

issue

7

1 reference

8 December 2017

page(s)

319-325

1 reference

Case Reports. Pulmonary cryptococcosis associated with cryptococcal meningitis in non-AIDS patients

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

Current approaches to diagnosis and treatment of fungal infections in children infected with human immuno deficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

The past, present and future of antimycotic combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2004.00998.X

10.1111/J.1439-0507.2004.00998.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference